Showing 381 - 400 results of 1,775 for search '"Therapy"', query time: 0.07s Refine Results
  1. 381

    Effect of combined therapy by pinaverium bromide and itopride hydrochloride on clinical semiology and quality of life of patients with combination of constipation variant of irritable bowel syndrome and functional dyspepsia by O. V. Krapivnaya, S. A. Alekseyenko

    Published 2015-05-01
    “…Application of the combined therapy including spasmolytic drug pinaverium bromide and prokinetic agent itopride hydrochloride for patients combination of IBS-C and PDS significantly increased efficacy of relief of clinical symptoms of combined disease and improved quality of life of patients.…”
    Get full text
    Article
  2. 382
  3. 383

    "They gave us the right to choose." A qualitative study of preferences for differentiated service delivery location among recipients of antiretroviral therapy at Lighthouse Trust in Lilongwe Malawi. by Lisa Orii, Kate S Wilson, Jacqueline Huwa, Christine Kiruthu-Kamamia, Odala Sande, Agness Thawani, Astrid Berner-Rodoreda, Evelyn Viola, Hannock Tweya, Petros Tembo, Wapu Masambuka, Richard Anderson, Caryl Feldacker

    Published 2025-01-01
    “…Some differentiated service delivery (DSD) models for antiretroviral therapy (ART) allow stable recipients of care (RoC) to receive multi-month ART drug refills and complete rapid reviews in community sites. …”
    Get full text
    Article
  4. 384

    Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review by Karen S. Yee, David Alexanderian, Yidie Feng, Xiaowei Ren, Bernd Schweikert, Olulade Ayodele

    Published 2022-08-01
    “…**Objectives:** This study aimed to assess the impact of timing of enzyme replacement therapy (ERT) initiation and CI status on the clinical characteristics and HRU of patients with MPS II. …”
    Get full text
    Article
  5. 385
  6. 386
  7. 387
  8. 388

    Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial by Torben Hansen, Tina Vilsbøll, Filip Krag Knop, Alexander Sidelmann Christensen, Heidi Storgaard, Sofie Hædersdal

    Published 2018-10-01
    “…Sulfonylurea (SU) is used as a first-line therapy in HNF1A-diabetes. However, SU therapy may be problematic as it confers a high risk of hypoglycaemia. …”
    Get full text
    Article
  9. 389

    Efficacy of non-invasive ventilation and oxygen therapy on immunocompromised patients with acute hypoxaemic respiratory failure: protocol for a systematic review and meta-analysis of randomised controlled trials by Juhong Shi, Gang Liu, Meng Wang, Tao Wang, Yi Li, Yi Yang, Xuezhong Yu, Huadong Zhu, Yong Ma, Zongru Li, Lixi Zhang, Kun He, Jianqiang He

    Published 2017-06-01
    “…The use of non-invasive ventilation (NIV) or oxygen therapy among these patients remains controversial, according to the inconsistent results of several randomised clinical trials (RCTs). …”
    Get full text
    Article
  10. 390
  11. 391

    Cognitive behavioural therapy plus Kiesler Circle Training (CBT+) versus CBT only for patients with interpersonal problems: study protocol for a randomised controlled feasibility trial by Stephan Köhler, Philipp Sterzer, Eva-Lotta Brakemeier, Karen Ollrogge, Daniel Schulze, Eva Friedel, Nina Romanczuk-Seiferth, Anna-Lena Siegerist, Anne Guhn

    Published 2025-02-01
    “…All patients will receive individual, state-of-the-art cognitive behavioural therapy (CBT) during the study. They will be randomly assigned to one of two conditions: the experimental group will receive the KCT in group sessions, in addition to individual CBT, while the control group will receive only individual CBT. …”
    Get full text
    Article
  12. 392
  13. 393
  14. 394
  15. 395
  16. 396
  17. 397
  18. 398

    Fournier's disease and anaerobic paraproctitis – different clinical forms of same pathological process? by M. A. Yegorkin

    Published 2012-07-01
    Subjects: “…antibacterial and detoxication therapy…”
    Get full text
    Article
  19. 399
  20. 400